OTCMKTS:LCDX Caliber Imaging & Diagnostics (LCDX) Stock Price, News & Analysis → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free LCDX Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume1,520 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartShort InterestStock AnalysisChartShort Interest Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry About Caliber Imaging & Diagnostics Stock (OTCMKTS:LCDX)Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system. The company was formerly known as Lucid, Inc. and changed its name to Caliber Imaging & Diagnostics, Inc. in August 2012. Caliber Imaging & Diagnostics, Inc. was founded in 1991 and is headquartered in Andover, Massachusetts.Read More Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry LCDX Stock News HeadlinesFebruary 9, 2024 | nz.finance.yahoo.comCaliber Imaging & Diagnostics, Inc. (LCDX)February 1, 2024 | wsj.comCaliber Imaging & Diagnostics Inc.September 20, 2023 | markets.businessinsider.comCaliber Imaging & Diagnostic (LCDX) Gets a Hold from RBC CapitalJuly 14, 2023 | markets.businessinsider.comCaliber Imaging & Diagnostic (LCDX) Gets a Buy from Cantor FitzgeraldJuly 14, 2023 | markets.businessinsider.comCaliber Imaging & Diagnostic (LCDX) Receives a Sell from Morgan StanleyMarch 29, 2023 | marketwatch.comDiagnostic Imaging Market 2023: Growing Opportunities by 2028February 26, 2023 | marketwatch.comDiagnostic Imaging Services Market 2023 LATEST [ R and D ] INSIGHTS in Report of 122 Pages till 2028February 24, 2023 | benzinga.comIntroduction of Diagnostic and Supplemental Imaging Legislation Could Benefit Thousands of KentuckiansFebruary 22, 2023 | benzinga.comIntroduction of Diagnostic and Supplemental Imaging Legislation Could Benefit Thousands of TennesseansFebruary 11, 2023 | finance.yahoo.comCaliber Auto Care opens new center near San Antonio Medical CenterAugust 10, 2022 | benzinga.comCaliberMRI, Inc. Announces Award to Improve Pediatric Brain Imaging at More than 25 Sites Around the WorldJanuary 16, 2022 | nasdaq.comCaliber Imaging & Diagnostics Inc (LCDX)See More Headlines Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:LCDX CUSIPN/A CIKN/A Webwww.caliberid.com Phone585-239-9800FaxN/AEmployees28Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Key ExecutivesMr. William J. Shea (Age 76)Executive Chairman Mr. L. Michael Hone (Age 74)CEO & Director Comp: $350kMr. William J. Fox (Age 58)CTO & VP of Technology Operations Comp: $139.16kMs. Karen HoweChief Financial OfficerMr. Robert T. KelleyVice President of Sales & MarketingKey CompetitorsAinosNASDAQ:AIMDWBICO Group AB (publ)OTCMKTS:CLLKFBone BiologicsNASDAQ:BBLGWCell MedXOTCMKTS:CMXCCellaVision AB (publ)OTCMKTS:CLVSFView All Competitors LCDX Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Caliber Imaging & Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Caliber Imaging & Diagnostics investors own include Etsy (ETSY), J C Penney (JCP), NVIDIA (NVDA), Tesla (TSLA), Alibaba Group (BABA), Youdao (DAO), Advanced Micro Devices (AMD), Costco Wholesale (COST), International Business Machines (IBM) and Netflix (NFLX). How do I buy shares of Caliber Imaging & Diagnostics? Shares of LCDX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:LCDX) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDoes this make you sick?Allegiance GoldThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock Digest Adding Choose a watchlist: Watchlist My Default Watchlist Adding Caliber Imaging & Diagnostics, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
